Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
1.86M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
262K
-
Shares change
-
+205K
-
Total reported value, excl. options
-
$1.34M
-
Value change
-
+$1.05M
-
Number of buys
-
12
-
Number of sells
-
-8
-
Price
-
$5.13
Significant Holders of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (EKSO) as of Q3 2025
36 filings reported holding EKSO - EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.0001 par value per share as of Q3 2025.
EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (EKSO) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 262K shares
of 1.86M outstanding shares and own 14.04% of the company stock.
Largest 10 shareholders include Consolidated Portfolio Review Corp (64.9K shares), CITADEL ADVISORS LLC (38.6K shares), VANGUARD GROUP INC (35.5K shares), UBS Group AG (32.5K shares), DRW Securities, LLC (20.2K shares), Cresset Asset Management, LLC (18K shares), GEODE CAPITAL MANAGEMENT, LLC (14.9K shares), Shay Capital LLC (13K shares), Virtu Financial LLC (11.1K shares), and BlackRock, Inc. (3.65K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.